chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pruritis, swelling Narrative:  Pt developed itching on her hands and feet around 8:30 pm and broke out rashes, mainly on arms, chest, and hands; she took OTC Benadryl po and Tylenol. She took an additional dose of Benadryl that night; On Sunday am, her throat felt swollen and lymph nodes were swollen along with facial swelling; she took another dose of Benadryl and used cold compress on face. S.S are resolved. Per pt, she never had any allergic reaction to anything in the past. She has already reported online to CDC. Allergy Clinic consult recommended no further mRNA vaccinations.
Myalgia Pea-sized swollen blands noted on bilat neck, started  on left side progressed to bilat Narrative:
75 year old female received first dose of mRNA-1273 (Moderna) COVID vaccine on March 17, 2021.  One week after, patient experienced numbness/tingling in toes of both feet, which resolved after several days.  Also patient experienced a toothache for which she went to her dentist.  Dentist expected patient needed a root canal, but was surprised that x-rays showed no problem.  Patient received second dose of mRNA-1273 COVID vaccine approximately April 14, 2021 and experienced the usual chills and fatigue for 2 days.  On July 13, 2021 patient suffered an appendicitis.  In examining patient for the appendicitis, the patient was diagnosed with atrial fibrillation.   An appendectomy was performed and patient was admitted to hospital for 3 days observation of the A Fib. This the 6th woman of which she is aware who has had an appendectomy after their COVID vaccines. Patient is currently on blood thinner (Eliquis) for potential blood clot and medication for the A Fib.  She also had itchy welts on her legs, possibly an allergic reaction to the contrast dye used in diagnosing her appendicitis, or sequelae of the vaccine. Patient received no other vaccines between 4 weeks prior to the first dose and the present date.  Patient saw cardiologist July 30, 2021.  Patient now has recurring episodes of numbness/tingling in fingers and toes, with pain in her toes. Prior to the vaccine, patient was extremely fit and healthy, with no prior health problems other than osteoporosis.  She worked out 5 to 6 hours a day, 6 days a week at the gym, is very thin and has no prior history of A Fib or any heart problems.  Patient is irate her health has been compromised by the vaccine, regrets taking it and wants to warn others of the damage the COVID vaccine can do.
FEVER; NAUSEA; BLADDER INFECTION; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included allergy of antibiotic .The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805022, expiry: UNKNOWN) dose was not reported, administered on 18-MAR-2021 to left arm for prophylactic vaccination.  No concomitant medications were reported.  On 19-MAR-2021, the subject experienced fatigue. On 20-MAR-2021, the subject experienced bladder infection. On 21-MAR-2021, the subject experienced nausea. On 22-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from bladder infection, fever, and fatigue, and the outcome of nausea was not reported. This report was non-serious.; Sender's Comments: V0:  Medical Assessment comment not required as per standard procedure as the case assessed as non-serious.
swollen rash that is 4 inches like hives; This spontaneous case was reported by a consumer and describes the occurrence of RASH (swollen rash that is 4 inches like hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Autoimmune disorder.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, the patient experienced RASH (swollen rash that is 4 inches like hives). At the time of the report, RASH (swollen rash that is 4 inches like hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medication and treatment information were provided.
Child had  covid 19 booster ( already had primary 2 shot series of covid 19 vaccine 5 months prior to booster) on 5/26/22 around 5 pm per family. Started with some vomiting at 11:30am and fever 102.4 at 1 pm the next day on 5/27/22 per family. Family denies any reactions to primary series of covid vaccine.
Roderick complains of headaches, muscle aches, shooting sharp pain at injection site, warmth, soreness and swelling at site.
Information has been received from a physician concerning a 11-week-old female with no medical history who on 08-FEB-2007 was vaccinated PO with the first 2.0 mL dose of Rotateq. The physician reported that on 20-FEB-2007, the patient developed vomiting and diarrhea. Unspecified medical attention was sought and the patient was hospitalized for one night. No laboratory/diagnostic tests were performed. In February 2007, the patient's diarrhea and vomiting resolved. Additional information has been requested.
Patient received Hepatitis A vaccine at approx. 5:00 p.m. on 7/23/18. Great-grandmother called office the next day stating patient was having shortness of breath, and tingling in her hands and face. Great grandmother was advised to take pt. to the E.R. She stated she reacted to one of her vaccines like this last yr. she did not take pt. to ER. She gave her BENADRYL and VENTOLIN inhaler 2 puffs. Patient is fine.
Within a couple of days of the second SHINGRIX vaccination I experienced flu-like symptoms. Subsequent to that I experienced a burning sensation in my arm below the injection site. I am still experiencing burning and itching below the injection site (inside of left arm above the elbow). Feels like nerve damage. No rash. My doctor recommended I report this.
Patient has an area 5 cm in diameter of redness, swelling, induration, tenderness of the left thigh, which is also warm to the touch. Seen by doctor on 03/02/05, treated with Bactrim for 10 days.
In the late evening: redness & swelling of upper rt arm; fever; extremities cold; shaking; mild difficulty breathing; wheezing. Condition persisted for 6 hours. Tylenol taken.
1. hoarse voice approximately 1-2 days following vaccine 2. fever (ranging from 100.6-102.3, rectal) began 10 days after vaccine was administered, lasting approximately 2 days. 3. red dots on hands and 1 leg (may not be related), occurred approximately same time as fever
Pt recieved ZOSTAVAX without issues or problems.  Awoke next day with pain, redness, and itching. Continued to worsen through the day.  Presented at pharmacy today (11/18/2016) with an area of about 1 inch diameter inflamed, hot to touch, painful, and itchy.  Surrounding area of 4 to 5 inches diameter red, tender, itchy but less involved with definite border.  pt to use cold compresses, anti-inflamatory, and diphenhydramine.
Beginning around midnight after the vaccination, I developed flu-like symptoms. I had chills, body aches, headache, body fatigue and weakness. It lasted at least 36 hours.
Sudden, sustained high blood pressure. First measurement was 175/93 on 1/26 at approximately 10:00 p.m. Subsequent measurements generally ranged from 153/102 to as high as 200/117 over the next several days until I saw Dr. on 1/31. Dr. prescribed Losartan 25mg daily. Took 1st dose on 1/31. Measurements have improved since 2nd dose of Losartan on 2/1, ranging from 121/73 to 163/96.
Day after vaccine adm raised rash with clear fluid vesicles warm at injection site gave Benadryl. Sat 30-40 vesicles, gone still red dots to elbow on right arm. Sun red dots are gone but still had sand paper like rash Benadryl given 2 more times no temp only soreness. Symptoms now resolved.
Patient experienced onset of COVID symptoms 05/26. Tested positive for SARS-COV-2 by PCR on 06/09. Presented to ER on 06/12/21 c/o cough, SOB, and hypoxia. O2 sat was 72%.  Patient was hospitalized and passed away on 06/18/2021.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 17-SEP-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 ten 0.5ml single-dose vial (SDV) (lot # K019561, expiration date 20-APR-2016). No adverse effects were reported. This specified lot number vaccine was exposed to temperature excursion twice. The total cumulative excursion time (hour), the highest recorded temperature (Fahrenheit degree/ Celsius) and the type of excursion (R/F) for each time were 24, 47 and R; 112, 49 and R. The storage criteria was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
He believes his veins was punctured, he was bleeding a lot; he believes his veins was punctured, he was bleeding a lot; sore arm for a couple of days; Very mild occasional cough on the day of the shot until he went to bed; Dizziness/ Mild lightheadness; Felt a little weird; Had really vivid cool dreams; may not have gotten the full dose; Shot was given in his upper arm, but not intramuscularly/shot was given in his veins (4mL in his muscles and 1mL in his veins); Felt fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VEIN RUPTURE (He believes his veins was punctured, he was bleeding a lot) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) 1 dosage form. On 06-Apr-2021, the patient experienced VEIN RUPTURE (He believes his veins was punctured, he was bleeding a lot) (seriousness criterion medically significant), PUNCTURE SITE HAEMORRHAGE (he believes his veins was punctured, he was bleeding a lot), PAIN IN EXTREMITY (sore arm for a couple of days), COUGH (Very mild occasional cough on the day of the shot until he went to bed), DIZZINESS (Dizziness/ Mild lightheadness), FEELING ABNORMAL (Felt a little weird), ABNORMAL DREAMS (Had really vivid cool dreams), UNDERDOSE (may not have gotten the full dose), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Shot was given in his upper arm, but not intramuscularly/shot was given in his veins (4mL in his muscles and 1mL in his veins)) and FATIGUE (Felt fatigue). At the time of the report, VEIN RUPTURE (He believes his veins was punctured, he was bleeding a lot), PUNCTURE SITE HAEMORRHAGE (he believes his veins was punctured, he was bleeding a lot), PAIN IN EXTREMITY (sore arm for a couple of days), COUGH (Very mild occasional cough on the day of the shot until he went to bed), DIZZINESS (Dizziness/ Mild lightheadness), FEELING ABNORMAL (Felt a little weird), ABNORMAL DREAMS (Had really vivid cool dreams), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Shot was given in his upper arm, but not intramuscularly/shot was given in his veins (4mL in his muscles and 1mL in his veins)) and FATIGUE (Felt fatigue) outcome was unknown and UNDERDOSE (may not have gotten the full dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) was unknown.       No concomitant medications or treatment drugs were reported.  Company comment : Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-110191 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
21mins post vaccination pt reported dizziness, chest discomfort and HA. Vitals: 101/62, 71, 16, 100%, 97.8F Pt stable and released from the vaccination site.  Recommended the the pt f/u w/ PCP.
This is a spontaneous report obtained from a contactable pharmacist  through a Pfizer sales representative. A patient of an unspecified age, ethnicity and gender received PREVNAR 13 on an unknown date, at 0.5 ml, single dose, for immunization. It was the only vaccine administered. Relevant medical history and concomitant medications were unknown. On an unspecified date, the patient experienced redness and swelling at injection site. Clinical outcome of the events was unknown at time of this report. The events were considered related to pneumococcal 13-val conj vac (dipht crm197 protein).
Patient called on 9/18 to report what she believed was an adverse reaction to the Shingrix vaccination she received on 9/14/18. She reported having developed a rash on the inside of both thighs on the night of 9/17/18. Per patient, the rash felt hot to the touch but was not itchy or painful. She did not have any reaction, including this one, the first time she received the first dose of Shingrix on 4/24/18.  Informed patient to call back the pharmacy or doctor's office if rash worsened or other symptoms developed.
PER CHILD'S FATHER'S CONVERSATION WITH DR ON 11/25/2019 - AFTER 8/2/2016 VISIT WITH DR CHILD WAS TREMULOUS BUT THAT WENT AWAY. HE THEN STARTED WITH A WET COUGH THAT LASTED AN ENTIRE YEAR. FINALLY HE WAS DX WITH ACHALASIA PROBABLY COUGH WAS THE FIRST SIGN. DR INFORMED FATHER THAT BETWEEN 2016 & 2018 THAT HIS CHILD DID NOT COME TO US FOR CARE.
died after taking the Pfizer COVID-19 vaccine with "no other health issues"; This is a spontaneous report received from non-contactable reporters (Consumers or other non HCPs) from medical information team.  A 27 year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "died after taking the Pfizer COVID-19 vaccine with "no other health issues"". The patient's date of death was unknown. It was not reported if an autopsy was performed.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: There is very limited information provided in this report to make a robust medical judgment regarding the causality of the event. This consumer report lacks confirmation from a healthcare professional. Confirmation from the patient's treating physician would be helpful. Information regarding the patient's significant medical history and use concomitant medications.  An autopsy report would be useful if this was done. This case will be reassessed upon receipt of follow-up information.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.; Reported Cause(s) of Death: died after taking the Pfizer COVID-19 vaccine with "no other health issues"
(L) sided muscle and joint pain affecting neck, shoulder, elbow, hip, knee, as reported by patient.
Diagnosed Pericarditis; This is a spontaneous report from a contactable other healthcare professional (patient). A 55-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, at age of 55-year-old), via an unspecified route of administration, administered in right arm on 13Apr2021 at 13:15 as single dose for covid-19 immunization. Medical history was none. No known allergies. Concomitant medications included atorvastatin, carvedilol and telmisartan. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, at age of 55-year-old), via an unspecified route of administration, administered in left arm on 21Mar2021 at 13:15 as single dose for covid-19 immunization. The patient experienced diagnosed pericarditis on 05May2021 at 12:00 PM, resulted in emergency room/department or urgent care, and treatment included 800 mg Ibuprofen. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Patient had covid test post vaccination on 09May2021 and type was nasal swab, result was negative. The outcome of the event was recovered with sequelae on an unspecified date in 2021.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a possible contributory role of the suspect vaccine to the reported event pericarditis cannot be completely excluded based on temporal association and known drug safety profile.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
She has had her tongue coming out; Partial dyskinesia; This spontaneous case was reported by a consumer and describes the occurrence of TONGUE DISORDER (She has had her tongue coming out) and DYSKINESIA (Partial dyskinesia) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Intellectual disability.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TONGUE DISORDER (She has had her tongue coming out) and DYSKINESIA (Partial dyskinesia). At the time of the report, TONGUE DISORDER (She has had her tongue coming out) and DYSKINESIA (Partial dyskinesia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Follow-up information received on 21-JUN-2021 .Reporter contact details were updated and Patient initials was updated On 22-Jun-2021: Non-significant Follow-up appended
Patient received Covid (Moderna)vaccine to Right Deltoid IM injection and was in her 30 minute wait/monitor time and reported  that she was having a "weird feeling in throat." notified RN and 2 nurses went to patients vehicle. Patient reports at that time "I am having a  numbing feeling in throat and it feels like I need to keep clearing my throat. I keep coughing and needing to clear my throat and im not sure whats happening. Patients also states she is not sure if throat is closing but knows it is not normal." RN questioned her anxiety level at this time and meds, and if she was sick at all before vaccine with cough or scratchy throat. Patient answered no to all questions and states this just started after vaccine admin. HR WNL, BP  168/98, no SOB.  RN administered 50mg/ml x1ml )IM to left deltoid w/o difficulties. Patient monitored for an additional 30 minutes. RN checked on patient again at 30 minutes and patient reports "throat was feeling much better with no numbness or tingling and she felt that she was ok." Patient was observed by RN swallowing water w/o any difficulties. Drove patient home after event. RN called patient at 12:13 p.m . 01/22/2021 to check on her, and patient states "I am doing fine at home and plan to go shopping later."
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 03-DEC-2013 the patient was inadvertently administered a dose of ZOSTAVAX, subcutaneous (lot number J008434, expiring 11-OCT-2014) that had been improperly stored. There were no adverse effects reported. Additional information has been requested.
Dry throat; Numbness around nose and upper lip; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: unknown) via unspecified route of administration in the left arm on 25Mar2021 at 10:45 (at the age of 58-years-old), as a single dose for COVID-19 immunisation. Medical history included hashimoto hypothyroidism. The patient did not have a history of allergies to medications, food, or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient had not tested for COVID-19. Concomitant medications included LEVOXYL, ADVIL, cyclobenzaprine (MANUFACTURER UNKNOWN); all for an unknown indication. On 25Mar2021 at 11:00, the patient had experienced dry throat, numbness around nose and upper lip. The patient did not receive treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dry throat, numbness around nose and upper lip was unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Rash, itching, redness, warm to touch at injection site, chest tightness. Advised to seek primary MD for further consult.
Nausea, vomiting, diarrhea, chills and fever, fatigue, PO2 dropped into high 80's.  Diarrhea lasted about 24 hours, N/V about 48 hours.  Chills ("teeth clattering") lasted 36 hour and fever (subjective, temp not taken by patient) lasted about 48+ hours.  At 5 days post vaccine, PO2 is back up to 97 and she has only fatigue.
Information has been received from a registered nurse concerning a currently 4 year old patient of unknown gender. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not provided. On an unknown date, the patient was vaccinated with VARIVAX (lot #: M033906 with expiration date: 28-JUL-2018) (dosage schedule, route of administration and anatomical location were not reported), for prophylaxis. The administered vaccine was improperly stored at temperature greater than 15°F but less than 46 °F  (15.5 °F) for 30 minutes and at temperature greater than 6 °F but less than 14 °F (10.1 °F) for 1.5 hours without any previous temperature excursion; this information was registered in a digital data logger. No adverse effects were reported. This is one of several reports from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1704USA001065: US-009507513-1704USA001070: US-009507513-1704USA001067: US-009507513-1704USA001068: US-009507513-1704USA001069: US-009507513-1703USA012554: US-009507513-1704USA001066.
Shoulder is still sore; A spontaneous report was received from a consumer concerning a 80-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and patient's shoulder was sore/ arthralgia.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 12 Feb 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (batch: 039K20A) intramuscularly for prophylaxis of COVID-19 infection.  On 12 Feb 2021, the patient's shoulder was sore. No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not provided.  The outcome of event, shoulder was sore was unknown.
pt recv vax 27FEB98 & 1MAR98 rash occurred to lt thigh then included lt leg & rt leg w/in 24hr;no c/o fever, vomiting or loose stools;6MAR98 foster mom states site is pink w/ 4x3in area;